国新健康
(000503)
| 流通市值：88.91亿 | | | 总市值：88.92亿 |
| 流通股本：9.79亿 | | | 总股本：9.79亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 170,401,734.11 | 95,530,059.44 | 50,467,725.8 | 356,896,420.31 |
| 营业收入 | 170,401,734.11 | 95,530,059.44 | 50,467,725.8 | 356,896,420.31 |
| 二、营业总成本 | 323,277,664.25 | 200,420,486.66 | 101,542,262.28 | 497,601,832.31 |
| 营业成本 | 179,182,098.76 | 110,047,478.56 | 57,930,039.64 | 302,447,456.39 |
| 税金及附加 | 842,561.9 | 418,063.1 | 58,673.38 | 2,479,857.35 |
| 销售费用 | 50,376,899.05 | 32,429,165.35 | 14,923,130.53 | 72,270,820.15 |
| 管理费用 | 84,772,819.82 | 52,039,538.03 | 26,425,606.59 | 118,099,931.98 |
| 研发费用 | 1,568,783.86 | 1,209,670.2 | 542,165.06 | 339,291.6 |
| 财务费用 | 6,534,500.86 | 4,276,571.42 | 1,662,647.08 | 1,964,474.84 |
| 其中:利息费用 | 7,770,877.02 | 4,725,108.46 | 2,187,521.63 | 8,310,544 |
| 其中:利息收入 | 1,531,369.06 | 739,230.77 | 605,842.61 | 6,520,652.18 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 0 | - | 6,340,000 |
| 加:投资收益 | 16,565,620.64 | 9,609,001.83 | 4,320,158.46 | 143,019,379.11 |
| 净敞口套期收益 | - | - | - | 0 |
| 资产处置收益 | -10,565.71 | -5,713.81 | 0 | 33,591.2 |
| 资产减值损失(新) | 3,485,663.04 | 4,757,551.95 | -1,940,358.04 | -1,961,491.58 |
| 信用减值损失(新) | -5,331,635.44 | -8,231,174.76 | 3,398,061.31 | -23,186,486.13 |
| 其他收益 | 428,784.1 | 401,358.81 | 376,689.71 | 690,739.95 |
| 四、营业利润 | -137,738,063.51 | -98,359,403.2 | -44,919,985.04 | -15,769,679.45 |
| 加:营业外收入 | 57,806.21 | 16,738.59 | 6,257.87 | 5,664,099.58 |
| 减:营业外支出 | 313,904.45 | 313,744.29 | 38,008.68 | 1,586,974.34 |
| 五、利润总额 | -137,994,161.75 | -98,656,408.9 | -44,951,735.85 | -11,692,554.21 |
| 减:所得税费用 | 435,142.9 | 434,276.5 | 624,803.12 | -226,004.45 |
| 六、净利润 | -138,429,304.65 | -99,090,685.4 | -45,576,538.97 | -11,466,549.76 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -138,429,304.65 | -99,090,685.4 | -45,576,538.97 | -11,466,549.76 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -138,429,304.65 | -99,090,685.4 | -45,576,538.97 | -10,375,438.31 |
| 少数股东损益 | - | - | - | -1,091,111.45 |
| 扣除非经常损益后的净利润 | -138,186,108.39 | -98,811,329.49 | -45,568,538.16 | -151,674,390.39 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.14 | -0.1 | -0.05 | -0.01 |
| (二)稀释每股收益 | -0.14 | -0.1 | -0.05 | -0.01 |
| 八、其他综合收益 | -152,869.38 | -53,426.06 | -17,300.36 | -1,315,518.23 |
| 归属于母公司股东的其他综合收益 | -152,869.38 | -53,426.06 | -17,300.36 | -1,315,518.23 |
| 九、综合收益总额 | -138,582,174.03 | -99,144,111.46 | -45,593,839.33 | -12,782,067.99 |
| 归属于母公司股东的综合收益总额 | -138,582,174.03 | -99,144,111.46 | -45,593,839.33 | -11,690,956.54 |
| 归属于少数股东的综合收益总额 | 0 | - | - | -1,091,111.45 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |